LOCAL MULTIFUNCTIONAL HYDROGEL THERAPY IN EXPERIMENTAL FIBRINOPURULENT PERITONITIS: ANTIBACTERIAL, FIBRINOLYTIC, AND REPARATIVE EFFECTS OF A NOVEL LEVOFLOXACIN-CUCUMAZINE-NA-CMC COMPOSITE

DIGITAL OBJECT IDENTIFIER (DOI): https://doi.org/10.67620/sai.57d0008
Turakulov U1 , Mardonov J2 , Ergashev F3 , Kurbonova D4 , Sadikov R5
1 Center for the development of professional qualifications of medical workers (Tashkent, Uzbekistan), Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov (Tashkent, Uzbekistan).
2 Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov (Tashkent, Uzbekistan), Tashkent State Medical University (Tashkent, Uzbekistan).
3 Central hospital of the Kokand city medical association (Kokand, Uzbekistan), Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov (Tashkent, Uzbekistan).
4 Kokand city infectious diseases hospital (Kokand, Uzbekistan)
5 Republican Specialized Scientific and Practical Medical Center of Surgery named after Academician V. Vakhidov (Tashkent, Uzbekistan), Tashkent State Medical University (Tashkent, Uzbekistan)
ReceivedJul 06, 2026
RevisedJul 21, 2026
PublishedJul 26, 2026

Annotatsiya

Fibrinopurulent peritonitis (FPP) remains one of the most severe and life-threatening forms of intra-abdominal infection, with mortality rates ranging from 20% to 30% despite substantial advances in surgical source control, antimicrobial therapy, and intensive care management. The formation of extensive fibrinous deposits and bacterial biofilms within the peritoneal cavity creates a physical and biological barrier that significantly impairs the penetration and effectiveness of systemic antimicrobial agents, promotes persistent infection, enhances local inflammatory responses, and contributes to the development of postoperative adhesions and intra-abdominal abscesses. Objective: To develop and experimentally evaluate the therapeutic efficacy, biocompatibility, and reparative potential of a novel multifunctional composite hydrogel containing levofloxacin, cucumazine, and sodium carboxymethylcellulose (LCSC) for local treatment of fibrinopurulent peritonitis. Materials and Methods: The efficacy study was performed on 84 adult white rats with experimentally induced fibrinopurulent peritonitis using a modified distal cecal ligation and puncture (DCLP) model that closely reproduces the clinical and morphological features of diffuse peritonitis in humans. Animals were randomly assigned to three groups: control (saline lavage), levofloxacin (0.1% levofloxacin solution), and experimental (local application of LCSC hydrogel). Clinical, microbiological, histological, and morphometric assessments were performed on postoperative days 3, 7, 14, and 21. The evaluated parameters included mortality, bacterial contamination of peritoneal exudate, adhesion formation, serosal thickness, fibrosis area, inflammatory cell density, and degree of mesothelial epithelialization. Results: Local administration of the LCSC hydrogel resulted in improvements in the evaluated outcomes compared with standard treatment. Mortality decreased from 41.7% in the control group to 8.3% in the experimental group (p < 0.05). Bacterial contamination of the peritoneal exudate decreased from 10⁵-10⁶ CFU/mL to ≤10⁴ CFU/mL, while exudate volume was reduced by 30-40%. Morphometric analysis demonstrated a 46% reduction in fibrosis area, a 62% decrease in inflammatory cell infiltration, and an increase in epithelialization from 38 ± 5% to 72 ± 6% (p < 0.001). Histological examination revealed accelerated angiogenesis, early maturation of granulation tissue, and restoration of mesothelial integrity; no dense intra-abdominal adhesions were observed by day 21. Conclusions: The newly developed LCSC composite hydrogel demonstrated pronounced antibacterial, fibrinolytic, anti-inflammatory, anti-adhesive, and reparative properties in an experimental model of fibrinopurulent peritonitis. The combination of sustained local antimicrobial delivery, enzymatic fibrin degradation, and promotion of mesothelial regeneration provides a multifactorial pathogenetic effect that may represent a promising strategy for improving the outcomes of local treatment of severe intra-abdominal infections.

Kalit so'zlar

fibrinopurulent peritonitis, hydrogel, levofloxacin, cucumazine, sodium carboxymethylcellulose, local therapy, fibrinolysis, biofilms, morphology, adhesions, mesothelial regeneration.

Foydalanilgan adabiyotlar

1. Sartelli M, Coccolini F, Kluger Y, Abu-Zidan FM, Ansaloni L, Bala M, et al. WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg. 2021;16:49. 2. Ceresoli M, Coccolini F, Fugazzola P, Tomasoni M, Sartelli M, Catena F. Enhanced perioperative care in emergency general surgery: the WSES position paper. World J Emerg Surg. 2023;18:47. 3. Ouaïssi M, Gaujoux S, Veyrie N, Denève E, Brigand C, Castel B, et al. Postoperative adhesions after digestive surgery: their incidence and prevention: review of the literature. J Visc Surg. 2012;149(2):e104-e114. 4. Bi Y, Li J, Yu Y, Wang Y, Zhang X, Chen H. Therapeutic strategies against bacterial biofilms. Fundam Res. 2021;1(2):193-212. 5. Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14(9):563-575. 6. Fleming D, Chahin L, Rumbaugh K. Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds. Antimicrob Agents Chemother. 2017;61(2):e01998-16. 7. Ishida H, Ishida Y, Kurosaka Y, Otani T, Sato K, Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1998;42(7):1641-1645. 8. Elviri L, Bianchera A, Bergonzi MC, Bettini R. Controlled local drug delivery strategies from chitosan hydrogels for wound healing. Expert Opin Drug Deliv. 2017;14(7):897-908. 9. Liang X, Huang C, Liu H, Chen H, Shou J, Cheng H, Liu G. Natural hydrogel dressings in wound care: design, advances, and perspectives. Chin Chem Lett. 2024;35(10):109442. 10. Alberts A, Moldoveanu ET, Niculescu AG, Grumezescu AM. Hydrogels for wound dressings: applications in burn treatment and chronic wound care. J Compos Sci. 2025;9(3):133. 11. Andresen AK, Felding MS, Sacramento MMA, Nielsen LH. Hydrogel-based drug delivery systems for localized eradication of bacterial biofilms: advances, challenges and future directions. J Control Release. 2026;390:114509. 12. Mirghani R, Saba T, Khaliq H, Mitchell J, Do L, Chambi L, et al. Biofilms: formation, drug resistance and alternatives to conventional approaches. AIMS Microbiol. 2022;8(3):239-277. 13. Singh B, Dahiya M, Kumar V, Ayyagari A, Chaudhari DN, Ahire JJ. Biofilm and antimicrobial resistance: mechanisms, implications, and emerging solutions. Microbiol Res. 2025;16(8):183. 14. Fang CC, Chou TH, Lin GS, Yen ZS, Lee CC, Chen SC. Peritoneal infusion with cold saline decreased postoperative intra-abdominal adhesion formation. World J Surg. 2010;34(4):721-727. 15. Mazuski JE, Tessier JM, May AK, et al. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. Surg Infect. 2017;18(1):1-76. 16. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133-164. 17. Montravers P, Dupont H, Leone M, Constantin JM, Mimoz O, Veber B, et al. Guidelines for management of intra-abdominal infections. Anaesth Crit Care Pain Med. 2015;34(2):117-130. 18. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95-108. 19. Hellebrekers BWJ, Kooistra T. Pathogenesis of postoperative adhesion formation. Br J Surg. 2011;98(11):1503-1516. 20. Arung W, Meurisse M, Detry O. Pathophysiology and prevention of postoperative peritoneal adhesions. World J Gastroenterol. 2011;17(41):4545-4553. 21. Diamond MP, Wexner SD, diZerega GS, Korell M, Zmora O, Van Goor H, Kamar M. Adhesion prevention and reduction: current status and future recommendations of a multinational interdisciplinary consensus conference. Surg Innov. 2010;17(3):183-188. 22. ten Broek RPG, Issa Y, van Santbrink EJP, Bouvy ND, Kruitwagen RFPM, Jeekel J, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and meta-analysis. BMJ. 2013;347:f5588. 23. Van Goor H. Consequences and complications of peritoneal adhesions. Colorectal Dis. 2007;9(Suppl 2):25-34. 24. Parker MC, Wilson MS, Menzies D, et al. Clinical and economic consequences of postoperative adhesions. Eur J Surg Suppl. 2001;577:5-9. 25. Attard JA, MacLean AR. Adhesive small bowel obstruction: epidemiology, biology and prevention. Can J Surg. 2007;50(4):291-300. 26. Singleton KD, Wischmeyer PE. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res. 2003;35(6):486-491.

Maqolaga iqtibos keltirish andozasi

Turakulov U, Mardonov J, Ergashev F, Kurbonova D, Sadikov R (2026). LOCAL MULTIFUNCTIONAL HYDROGEL THERAPY IN EXPERIMENTAL FIBRINOPURULENT PERITONITIS: ANTIBACTERIAL, FIBRINOLYTIC, AND REPARATIVE EFFECTS OF A NOVEL LEVOFLOXACIN-CUCUMAZINE-NA-CMC COMPOSITE. Science and Innovation, 5(7), 65-81. https://doi.org/10.67620/sai.57d0008